Cardiac structure and diastolic function in mild primary hyperparathyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 5, 2010, Pages 2172-2179

  Walker, M D ^a   Fleischer, J B ^a   Di Tullio, M R ^a   Homma, S ^a   Rundek, T ^b   Stein, E M ^a   Zhang, C ^a   Taggart, T ^a   McMahon, D J ^a   Silverberg, Shonni J ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL ANNULAR CALCIFICATION; MITRAL VALVE DISEASE; PARATHYROID HORMONE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TISSUE DOPPLER IMAGING; UNIVERSITY HOSPITAL; VITAMIN BLOOD LEVEL; BODY MASS; CALCINOSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART; HEART VENTRICLE; HISTOLOGY; HYPERTENSION; MIDDLE AGED; MITRAL VALVE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AGED; BLOOD FLOW VELOCITY; BODY MASS INDEX; CALCINOSIS; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART VENTRICLES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; HYPERTENSION; MALE; MIDDLE AGED; MITRAL VALVE; RISK FACTORS; ULTRASONOGRAPHY, DOPPLER; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77952766947     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2072     Document Type: Article

References (51)

1. Palmér M, Adami HO, Bergström R, Akerström G, Ljunghall S 1987 Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery 102:1-7
2. Hedbäck G, Tisell LE, Bengtsson BA, Hedman I, Odén A 1990 Premature death in patients operated on for primary hyperparathyroidism. World J Surg 14:829-835; discussion 836
3. Hedbäck G, Odén A, Tisell LE 1991 The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World J Surg 15:399-405; discussion 406-407
4. Hedbäck G, Odén A 1999 Survival of patients operated on for primary hyperparathyroidism. Surgery 125:240-241
5. Hedbäck G, Odén A 1998 Increased risk of death from primary hyperparathyroidism-an update. Eur J Clin Invest 28:271-276 (Pubitemid 28188301)
6. Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A 2002 Clinical presentation of primary hyperparathyroidism in Europe-nationwide cohort analysis on mortality from nonmalignant causes. J Bone Miner Res 17(Suppl 2):N68-N74
7. Øgard CG, Engholm G, Almdal TP, Vestergaard H 2004 Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark. World J Surg 28:108-111
8. Wermers RA, Khosla S, Atkinson EJ, Grant CS, Hodgson SF, O'Fallon WM, Melton 3rd LJ 1998 Survival after the diagnosis of hyperparathyroidism: a population-based study. Am J Med 104:115-122
9. Kardys I, Deckers JW, Stricker BH, Vletter WB, Hofman A, Witteman JC 2009 Echocardiographic parameters and all-cause mortality: the Rotterdam Study. Int J Cardiol 133:198-204
10. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP 1990 Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561-1566
11. Gardin JM, McClelland R, Kitzman D, Lima JA, Bommer W, Klopfenstein HS, Wong ND, Smith VE, Gottdiener J 2001 M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol 87:1051-1057
12. Almqvist EG, Bondeson AG, Bondeson L, Nissborg A, Smedgård P, Svensson SE 2002 Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery 132:1126-1132; discussion 1132
13. Dalberg K, Brodin LA, Juhlin-Dannfelt A, Farnebo LO 1996 Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur J Surg 162:171-176 (Pubitemid 126439593)
14. Näppi S, Saha H, Virtanen V, Limnell V, Sand J, Salmi J, Pasternack A 2000 Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy. Cardiology 93:229-233
15. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F, Borretta G 1999 Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50:321-328
16. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B 1997 Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 82:106-112
17. Stefenelli T, Globits S, Bergler-Klein J, Woloszczuk W, Längle F, Niederle B 1993 [Cardiac changes in patients with hypercalcemia]. Wien Klin Wochenschr 105:339-341
18. Barletta G, De Feo ML, Del Bene R, Lazzeri C, Vecchiarino S, La Villa G, Brandi ML, Franchi F 2000 Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J Clin Endocrinol Metab 85:1815-1821
19. Nuzzo V, Tauchmanovà L, Fonderico F, Trotta R, Fittipaldi MR, Fontana D, Rossi R, Lombardi G, Trimarco B, Lupoli G 2002 Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol 147:453-459
20. Nilsson IL, Aberg J, Rastad J, Lind L 2000 Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 128:895-902
21. Mogelvang R, Sogaard P, Pedersen SA, Olsen NT, Marott JL, Schnohr P, Goetze JP, Jensen JS 2009 Cardiac dysfunction assessed by echocardiographic tissue Doppler imaging is an independent predictor of mortality in the general population. Circulation 119:2679-2685
22. Baykan M, Erem C, Erdogan T, Ersoz HO, Gedikli O, Korkmaz L, Kucukosmanoglu M, Haclhasanoglu A, Kaplan S, Celik S 2007 Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 66:483-488
23. Ogino K, Burkhoff D, Bilezikian JP 1995 The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology 136:3024-3030
24. Schlüter KD, Piper HM 1992 Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes. Am J Physiol 263:H1739-H1746
25. Kamensky G, Lisy L, Polak E, Piknova E, Plevova N 2001 Mitral annular calcifications and aortic plaques as predictors of increased cardiovascular mortality. J Cardiol 37(Suppl 1):21-26
26. Kohsaka S, Jin Z, Rundek T, Boden-Albala B, Homma S, Sacco RL, Di Tullio MR 2008 Impact of mitral annular calcification on cardiovascular events in a multiethnic community: the Northern Manhattan Study. JACC Cardiovasc Imaging 1:617-623
27. Längle F, Abela C, Koller-Strametz J, Mittelböck M, Bergler-Klein J, Stefenelli T, Woloszczuk W, Niederle B 1994 Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J Surg 18:619-624
28. Stefenelli T, Mayr H, Bergler-Klein J, Globits S, Woloszczuk W, Niederle B 1993 Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am J Med 95:197-202
29. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, Paik MC, Hauser WA 1998 Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 147:259-268
30. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL 2005 Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 111:1327-1331
31. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ 2005 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440-1463
32. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N 1986 Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458
33. Simpson RU, Hershey SH, Nibbelink KA 2007 Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol 103:521-524
34. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP 2002 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the reninangiotensin system. J Clin Invest 110:229-238
35. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF 2008 Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 52:1949-1956
36. Xiang W, Kong J, Chen S, Cao LP, Qiao G, Zheng W, Liu W, Li X, Gardner DG, Li YC 2005 Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 288:E125-E132
37. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS 2008 Vitamin D deficiency and risk of cardiovascular disease. Circulation 117:503-511
38. Testa A, Mallamaci F, Benedetto F, Pisano A, Tripepi G, Thadhani R, Zoccali C 2010 Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts LVH progression in end stage renal disease (ESRD) patients. J Bone Miner Res 25(2):313-319
39. Silverberg SJ, Shane E, Dempster DW, Bilezikian JP 1999 The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. Am J Med 107:561-567
40. Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR, Talpos GB, Parfitt AM 2000 Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85:1054-1058
41. Ozbey N, Erbil Y, Ademoǧlu E, Ozarmaǧan S, Barbaros U, Bozbora A 2006 Correlations between vitamin D status and biochemical/clinical and pathological parameters in primary hyperparathyroidism. World J Surg 30:321-326 (Pubitemid 43261355)
42. Beyer TD, Chen EL, Nilubol N, Prinz RA, Solorzano CC 2007 Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency. J Surg Res 143:145-150 (Pubitemid 47562461)
43. Morgan JP 1991 Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325:625-632
44. Walker MD, Fleischer J, Rundek T, McMahon DJ, Homma S, Sacco R, Silverberg SJ 2009 Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab 94:3849-3856
45. Reis JP, von Muhlen D, Michos ED, Miller 3rd ER, Appel LJ, Araneta MR, Barrett-Connor E 2009 Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 207:585-590
46. Lafferty FW 1981 Primary hyperparathyroidism. Changing clinical spectrum, prevalence of hypertension, and discriminant analysis of laboratory tests. Arch Intern Med 141:1761-1766
47. Luboshitzky R, Chertok-Schaham Y, Lavi I, Ishay A 2009 Cardiovascular risk factors in primary hyperparathyroidism. J Endocrinol Invest 32:317-321
48. Bolland MJ, Grey AB, Gamble GD, Reid IR 2005 Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab 90:1525-1530
49. Nainby-Luxmoore JC, Langford HG, Nelson NC, Watson RL, Barnes TY 1982 A case-comparison study of hypertension and hyperparathyroidism. J Clin Endocrinol Metab 55:303-306
50. Hagstrom E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P, Rastad J 2002 Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: populationbased study over five years. Clin Endocrinol (Oxf) 56:253-260
51. Cardenas MG, Vigil KJ, Talpos GB, Lee MW, Peterson E, Rao DS 2008 Prevalence of type 2 diabetes mellitus in patients with primary hyperparathyroidism. Endocr Pract 14:69-75